News Releases
222 results
Other financial information
L'Oréal announces today that it has completed the sale of the home care business from the Cadum Group to Eau Ecarlate SAS.
Acquisitions
L’Oréal announces today that it has closed the acquisition of 100% of Cadum, the majority of which was held by investment fund Milestone.
In 2011, Cadum achieved consolidated sales of 58 million euros, 49 million euros of which in France, mainly with the brand Cadum.
Annual General Meeting
All the resolutions submitted to the Annual General Meeting were approved by a large majorityAppointment as Director of:
- Ms. Christiane Khuene,
- Mr. Paul Bulcke,
- Mr. Jean-Victor Meyers.Renewal of the tenure as Director of:
Sales
A promising start to the year
Sales: 5.64 billion euros
+9.4% based on reported figures +7.1% at constant exchange rates +6.4% like-for-like
Annual General Meeting
Information available concerning the Annual General Meeting to be held on Tuesday, April 17, 2012 and the 2011 Reference Document.
ANNUAL GENERAL MEETING SET FOR APRIL 17, 2012:
Governance
Tenures proposed for vote by next Annual General MeetingAppointment of Paul Bulcke, Christiane Kuehne and Jean-Victor Meyers as Board DirectorsRenewal of the tenures as Board Director of Jean-Pierre Meyers and Bernard Kasriel
L'Oréal's Board of Directors met today under the chairmanship of Jean-Paul Agon.
Governance
End of Board director tenure of Liliane BettencourtCooptation of Jean-Victor Meyers to Board of Directors
L'Oreal's Board of Directors was informed today of the end of Liliane Bettencourt's tenure as Board director.
Results
Sustained growth in sales
Solid increase in profits
Sales: 20.34 billion euros, +5.1% like-for-like*Strong improvement in operating margin: +50 bps** at 16.2%Record gross margin: +40 bps at 71.2%Net earnings per share***: +7.8%Increase in dividend****: +11% at 2 eurosConfidence in another year of sales and profit growth.
Acquisitions
Clarisonic® acquisition will boost L’Oreal’s innovation capacity in cosmetic devices
Acquisitions
L’Oréal USA and Pacific Bioscience Laboratories, Inc. (PBL) announced yesterday a signed merger agreement between L’Oréal USA and PBL. PBL’s Clarisonic® is the acknowledged market leader in the rapidly growing areas of sonic skin care devices, topicals and technology.
Since February 2022, regulated documents posted on the www.loreal-finance.com website have been secured and authenticated with the blockchain technology by Wiztrust. You can check the authenticity on the website www.wiztrust.com
